Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
Product Description
200mg Molnupiravir Tablets is an antiviral medication that has been developed for the treatment of COVID-19. The active form of the drug interferes with the virus's ability to replicate by introducing errors into its genetic material (RNA). This can lead to the production of nonviable virus particles. It is an oral medication and is available in tablet form. Molnupiravir works by inhibiting the replication of the SARS-CoV-2 virus, which is the virus that causes COVID-19. 200mg Molnupiravir Tablets are most effective when administered early in the course of COVID-19, ideally within the first few days of symptom onset.